Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRI-EXPLORE
jRCT2051250058Suspended
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in myocardial infarction (MI) comparing BI 765845 plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Infarct size at Day 5. Started Oct 2025; status: suspended.
02
Drugs
BI 765845
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on jRCT2051250058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051250058.